Emily Lindberg (Undeterred Capital) / VC Breakdown & Contact

About Emily Lindberg

Emily Lindberg serves as Associate and Head of Research at Undeterred Capital, combining investing responsibilities with a structured research function that remains uncommon at smaller early-stage firms. Her background includes experience as a Fellow at MPM BioImpact and active involvement in the Nucleate ecosystem, giving her a foundation in life sciences investing and biotech commercialization networks before joining Undeterred Capital.

Where they've Worked

This is some text inside of a div block.

Video Interview

On what VCs are actually evaluating -- and why great tech alone is not enough

"We might think the technology you’re working on is amazing, but there are many other factors to consider. You also need the right team, the right market and timing, a defensible product, and a clear path to achieving venture-scale returns."

Emily Lindberg

Associate, Undeterred Capital

On what makes a team slide stand out at the pre-seed stage

“Experience on both the technical and business side. Someone who can show they are actually able to break into the sector and engage with customers in the area they’re building in."

Emily Lindberg

Associate, Undeterred Capital

On getting defensive when discussing risks or competition

"Never say there is no competition, because that simply can’t be true. It’s far more powerful when founders acknowledge what they’re concerned about and what challenges may arise, while also clearly explaining how they plan to mitigate those risks."

Emily Lindberg

Associate, Undeterred Capital

Common reason startups fail

"Fitting tech to a problem versus developing a technology specifically for a problem. If the market's not there, the company's gonna have a really hard time succeeding."

Emily Lindberg

Associate, Undeterred Capital

About their Fund

Undeterred Capital

Sectors

Biotech, Robotics, Deeptech / Hardware, AI, Health

Rounds

Pre-Seed - Seed

Avg Check Size

$500K-1M

Notable Investments

This is some text inside of a div block.

Undeterred Capital focuses exclusively on the intersection of biological platforms and applied robotics, investing over 80% of their portfolio at pre-seed or earlier stages while writing unusually large checks ($500K–$1M) and frequently leading rounds in these capital-intensive domains. The fund is founder-led by a former deep-tech operator who built a pharma robotics company and scaled a COVID-era PPE logistics non-profit, with an unusually academic investment team including two PhDs and an explicit head of research function that productizes emerging deep-tech research for founders.

Other partners at the fund

No items found.